Vortex Biosciences is an oncology diagnostics company that integrates cancer biology, microfluidic engineering.
Vortex Biosciences has raised $4.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2023.
Vortex Biosciences's investors include EMV Capital, NetScientific PLC.
Vortex Biosciences is headquartered in Menlo Park, United States.
Vortex Biosciences is an oncology diagnostics company that integrates cancer biology, microfluidic engineering.
Vortex Biosciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vortex Biosciences — Funding & Investors." VCBacked, June 22, 2023, https://www.vcbacked.co/company/vortex-biosciences. Accessed August 14, 2026.
VCBacked. (2023). Vortex Biosciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/vortex-biosciences
{{cite web |title=Vortex Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/vortex-biosciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated